Complementary care

Natural peptides

A complementary offering explored individually, secondary to the ibogaine retreat. Described without claims about lowering blood pressure, thinning blood, producing stem cells or antibodies, amplified neurogenesis, guaranteed absence of side effects, or superior safety because a product is "natural."

From old wisdom to open questions

An ancient impulse, a modern conversation

The idea of drawing on the natural world for healing is old. Many indigenous traditions held that certain plants, venoms, and animal-derived substances carried knowledge a community could learn from — to be approached with respect, guidance, and care, not as a casual remedy. That ancestral wisdom is the roots of the impulse to look to nature for possibility.

Modern science has continued that conversation in a different register. Derivatives of naturally occurring peptides and venoms now appear in a range of licensed medications, and researchers across many fields are studying them as potential starting points for new treatments. That interest does not mean any particular substance is safe, proven, or appropriate for a given person — only that the questions are being asked.

We share this context because it is genuinely interesting, not because it establishes that Casa-Well's complementary offering is effective, approved, or a substitute for medical care. The research below is general scientific background. It is separate from our services and does not describe Casa-Well outcomes.

Selected research, for context

These are published studies and articles about peptide and venom-derived compounds in other settings. They are shared as background reading, not as proof that Casa-Well's offering works, that it treats any condition, or that these findings apply here. Each has its own methods, populations, and limitations.

  • Venom therapy in multiple sclerosis

    Multiple sclerosis · peer-reviewed research

    A review of how venom-derived compounds have been explored in relation to multiple sclerosis, including reported immune-modulating activity and the substantial open questions about mechanism, dosing, and safety in humans.

    Read the source
  • Venoms as an adjunctive therapy for Parkinson's disease: where are we now and where are we going?

    Parkinson's disease · peer-reviewed review

    A narrative review surveying venom-derived compounds as a potential adjunct in Parkinson's disease research — noting both early signals of interest and the significant translational gaps before any clinical use could be considered.

    Read the source
  • Venom peptides in cancer therapy: an updated review on cellular and molecular aspects

    Cancer research · peer-reviewed review

    An updated review of how certain venom peptides act on cells in laboratory studies of cancer, including the molecular pathways examined and the distance between preclinical findings and any approved treatment.

    Read the source
  • Black mamba venom beats morphine as a painkiller

    Pain research · science media coverage

    Reporting on research in which a peptide identified in black mamba venom showed pain-reducing activity in animal models. The coverage also notes the early, pre-human stage of the work and the risks that follow from venom's potency.

    Read the source
  • Snake venomics: fundamentals, recent updates, and a look to the next decade

    Venom science · peer-reviewed review

    A broad overview of how snake venoms are studied — the methods used to identify and characterize their components, and the open questions researchers see for the coming decade across discovery, safety, and translation.

    Read the source

What this research is not

  • A claim that Casa-Well uses the same substances, doses, or protocols studied here.
  • A claim that these findings apply to Casa-Well participants or predict any individual outcome.
  • Proof of safety, efficacy, or approval for any condition we may discuss.
  • A substitute for clinical tests, diagnosis, or care from a qualified clinician.

What we don't claim

  • That natural peptides lower blood pressure or thin the blood.
  • That they produce stem cells or antibodies, or amplify neurogenesis.
  • Guaranteed absence of side effects, or superior safety because a product is natural.
  • An optimal AI-selected therapy.
  • Current hospital partnerships, an active research program, or home-use protocols without documentation.

Ask about current availability

Contact the team to learn whether this offering is currently available and to discuss its scope, evidence, limitations, and risks. We do not classify products as supplements, herbal remedies, or approved medicines by inference.

Do not stop, taper, or change prescribed medication based on information on this website. Discuss any proposed changes with your prescribing clinician and the screening medical team.